(Q33922485)
Statements
1 reference
Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia (English)
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Francis Giles
1 reference
David Rizzieri
1 reference
Ronan Swords
1 reference
Tove Flem Jacobsen
1 reference
9 January 2012
1 reference
1 reference
36
1 reference
e71-3
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference